Anesthesia management of patients with laryngeal cancer who did not stop using flupentixol/melitracen tablets before surgery
Main Authors: | Yu Xiao, Jiahui Zhang, Lei Wang, Jinxia Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958423009867 |
Similar Items
-
Melitracen and flupentixol (deanxit) use disorder in Lebanon
by: Tharwat El Zahran, et al.
Published: (2023-05-01) -
Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia
by: Zhihong Zhao, et al.
Published: (2023-10-01) -
Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions
by: Wu L, et al.
Published: (2019-09-01) -
Beyond the counter: Navigating the landscape of Deanxit® dispensing – Insights from Jordanian community pharmacies
by: Rawand E. Ahmad, et al.
Published: (2024-03-01) -
Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial
by: Qian-Qian Wang, et al.
Published: (2022-12-01)